193 related articles for article (PubMed ID: 19179304)
1. Dysregulation of Frizzled 6 is a critical component of B-cell leukemogenesis in a mouse model of chronic lymphocytic leukemia.
Wu QL; Zierold C; Ranheim EA
Blood; 2009 Mar; 113(13):3031-9. PubMed ID: 19179304
[TBL] [Abstract][Full Text] [Related]
2. Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.
Lu D; Liu JX; Endo T; Zhou H; Yao S; Willert K; Schmidt-Wolf IG; Kipps TJ; Carson DA
PLoS One; 2009 Dec; 4(12):e8294. PubMed ID: 20011538
[TBL] [Abstract][Full Text] [Related]
3. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia.
Lu D; Zhao Y; Tawatao R; Cottam HB; Sen M; Leoni LM; Kipps TJ; Corr M; Carson DA
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3118-23. PubMed ID: 14973184
[TBL] [Abstract][Full Text] [Related]
4. Frizzled gene expression and negative regulation of canonical WNT-β-catenin signaling in mouse F9 teratocarcinoma cells.
Golenia G; Gatie MI; Kelly GM
Biochem Cell Biol; 2017 Apr; 95(2):251-262. PubMed ID: 28177772
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Frizzled 6 membrane mobility by FRAP supports G protein coupling and reveals WNT-Frizzled selectivity.
Kilander MB; Dahlström J; Schulte G
Cell Signal; 2014 Sep; 26(9):1943-9. PubMed ID: 24873871
[TBL] [Abstract][Full Text] [Related]
6. Selective modulation of Wnt ligands and their receptors in adipose tissue by chronic hyperadiponectinemia.
Wada N; Hashinaga T; Otabe S; Yuan X; Kurita Y; Kakino S; Ohoki T; Nakayama H; Fukutani T; Tajiri Y; Yamada K
PLoS One; 2013; 8(7):e67712. PubMed ID: 23861788
[TBL] [Abstract][Full Text] [Related]
7. Accelerated progression of chronic lymphocytic leukemia in Eμ-TCL1 mice expressing catalytically inactive RAG1.
Nganga VK; Palmer VL; Naushad H; Kassmeier MD; Anderson DK; Perry GA; Schabla NM; Swanson PC
Blood; 2013 May; 121(19):3855-66, S1-16. PubMed ID: 23502221
[TBL] [Abstract][Full Text] [Related]
8. PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model.
Motiwala T; Kutay H; Zanesi N; Frissora FW; Mo X; Muthusamy N; Jacob ST
Leukemia; 2015 Jun; 29(6):1350-9. PubMed ID: 25482129
[TBL] [Abstract][Full Text] [Related]
9. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
Ring L; Neth P; Weber C; Steffens S; Faussner A
Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
[TBL] [Abstract][Full Text] [Related]
10. Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway.
Miyakoshi T; Takei M; Kajiya H; Egashira N; Takekoshi S; Teramoto A; Osamura RY
Endocr Pathol; 2008; 19(4):261-73. PubMed ID: 19034702
[TBL] [Abstract][Full Text] [Related]
11. Dissecting the impact of Frizzled receptors in Wnt/β-catenin signaling of human mesenchymal stem cells.
Kolben T; Peröbner I; Fernsebner K; Lechner F; Geissler C; Ruiz-Heinrich L; Capovilla S; Jochum M; Neth P
Biol Chem; 2012 Dec; 393(12):1433-47. PubMed ID: 23152409
[TBL] [Abstract][Full Text] [Related]
12. FZD6 triggers Wnt-signalling driven by WNT10B
Cassaro A; Grillo G; Notaro M; Gliozzo J; Esposito I; Reda G; Trojani A; Valentini G; Di Camillo B; Cairoli R; Beghini A
Hematol Oncol; 2021 Aug; 39(3):364-379. PubMed ID: 33497493
[TBL] [Abstract][Full Text] [Related]
13. Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt.
O'Connell MP; Weeraratna AT
Pigment Cell Melanoma Res; 2009 Dec; 22(6):724-39. PubMed ID: 19708915
[TBL] [Abstract][Full Text] [Related]
14. Activation of Wnt signalling in acute myeloid leukemia by induction of Frizzled-4.
Tickenbrock L; Hehn S; Sargin B; Choudhary C; Bäumer N; Buerger H; Schulte B; Müller O; Berdel WE; Müller-Tidow C; Serve H
Int J Oncol; 2008 Dec; 33(6):1215-21. PubMed ID: 19020754
[TBL] [Abstract][Full Text] [Related]
15. Wnt-4 activates the canonical beta-catenin-mediated Wnt pathway and binds Frizzled-6 CRD: functional implications of Wnt/beta-catenin activity in kidney epithelial cells.
Lyons JP; Mueller UW; Ji H; Everett C; Fang X; Hsieh JC; Barth AM; McCrea PD
Exp Cell Res; 2004 Aug; 298(2):369-87. PubMed ID: 15265686
[TBL] [Abstract][Full Text] [Related]
16. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
[TBL] [Abstract][Full Text] [Related]
17. LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation.
Chen Z; Gao Y; Yao L; Liu Y; Huang L; Yan Z; Zhao W; Zhu P; Weng H
Oncogene; 2018 Jun; 37(23):3098-3112. PubMed ID: 29535420
[TBL] [Abstract][Full Text] [Related]
18. Essential roles of mesenchyme-derived beta-catenin in mouse Müllerian duct morphogenesis.
Deutscher E; Hung-Chang Yao H
Dev Biol; 2007 Jul; 307(2):227-36. PubMed ID: 17532316
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9 based gene editing of Frizzled class receptor 6 (FZD6) reveals its role in depressive symptoms through disrupting Wnt/β-catenin signaling pathway.
Han H; Xu M; Wang J; Li MD; Yang Z
J Adv Res; 2024 Apr; 58():129-138. PubMed ID: 37321345
[TBL] [Abstract][Full Text] [Related]
20. Comparison of gene expression of the oncogenic Wnt/β-catenin signaling pathway components in the mouse and human epididymis.
Wang K; Li N; Yeung CH; Cooper TG; Liu XX; Liu J; Wang WT; Li Y; Shi H; Liu FJ
Asian J Androl; 2015; 17(6):1006-11. PubMed ID: 26228040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
